| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 41.38B | 44.65B | 46.38B | 37.62B | 33.03B | 31.12B |
| Gross Profit | 2.83B | 2.54B | 4.26B | 1.87B | 1.56B | 134.00M |
| EBITDA | 2.42B | 2.23B | 4.00B | 1.60B | 1.28B | 17.00M |
| Net Income | 1.20B | 1.02B | 2.26B | 737.00M | 143.00M | -971.00M |
Balance Sheet | ||||||
| Total Assets | 42.34B | 42.49B | 43.82B | 40.20B | 36.81B | 34.04B |
| Cash, Cash Equivalents and Short-Term Investments | 11.63B | 4.70B | 14.80B | 9.31B | 16.28B | 7.45B |
| Total Debt | 4.19B | 5.68B | 8.96B | 9.41B | 9.71B | 9.98B |
| Total Liabilities | 31.15B | 31.63B | 34.07B | 32.77B | 30.01B | 27.27B |
| Stockholders Equity | 11.18B | 10.86B | 9.74B | 7.43B | 6.79B | 6.78B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -6.58B | 5.96B | -7.88B | 9.28B | -5.61B |
| Operating Cash Flow | 0.00 | -5.38B | 6.75B | -6.38B | 10.78B | -4.10B |
| Investing Cash Flow | 0.00 | -1.20B | -824.00M | -249.00M | -1.68B | -1.53B |
| Financing Cash Flow | 0.00 | -3.44B | -528.00M | -359.00M | -278.00M | 1.71B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥311.50B | 8.58 | 16.64% | 1.36% | 0.58% | -24.42% | |
72 Outperform | ¥617.03B | 17.86 | 13.69% | 0.60% | 7.78% | -53.68% | |
70 Outperform | ¥18.01B | 96.92 | ― | 5.14% | -13.63% | -74.53% | |
70 Outperform | ¥12.11B | 2.74 | ― | 2.71% | 2.02% | 27.03% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥24.29B | 12.29 | ― | 0.27% | 1.60% | 314.05% | |
59 Neutral | ¥4.25B | -19.32 | ― | 0.67% | -3.25% | 45.54% |